NCT04296942 2022-01-11BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)National Institutes of Health Clinical Center (CC)Phase 1 Terminated1 enrolled 10 charts